Is GALKF or MRK a better dividend investment in 2026?

GALKF currently yields 1333.33% with a 5% 5-year dividend growth rate. MRK yields 2.76% with 8.2% growth. The better choice depends on your goal: GALKF offers higher current income.

What is the dividend yield difference between GALKF and MRK?

GALKF has a forward dividend yield of 1333.33% ($2.00/share annually). MRK yields 2.76% ($3.32/share annually). The yield gap is 1330.57 percentage points.

Home › Compare › GALKF vs MRK

GALKF vs MRK: Dividend Comparison 2026

GALKF yields 1333.33% · MRK yields 2.76%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 GALKF wins by $241528700.55M in total portfolio value

INVESTMENT

TIME HORIZON10 years

GALKF

● Live price

1333.33%

Share price

$0.15

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$241528700.61M

Annual income

$210,475,860,072,406.56

Full GALKF calculator →

MRK

Merck & Co. Inc.

● Live price

2.76%

Share price

$120.31

Annual div

$3.32

5Y div CAGR

32.7%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$56.8K

Annual income

$9,798.13

Full MRK calculator →

Portfolio growth — GALKF vs MRK

📍 GALKF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	GALKF	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, GALKF + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

GALKF pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GALKF

Annual income on $10K today (after 15% tax)

$113,333.33/yr

After 10yr DRIP, annual income (after tax)

$178,904,481,061,545.56/yr

MRK

Annual income on $10K today (after 15% tax)

$234.56/yr

After 10yr DRIP, annual income (after tax)

$8,328.41/yr

At 15% tax rate, GALKF beats the other by $178,904,481,053,217.16/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GALKF + MRK for your $10,000?

GALKF: 50%MRK: 50%

100% MRK50/50100% GALKF

Portfolio after 10yr

$120764350.33M

Annual income

$105,237,930,041,102.34/yr

Blended yield

87.14%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

GALKF

No analyst data

Altman Z

-12.6

Piotroski

2/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+6.8% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GALKF buys

MRK buys

No recent congressional trades found for GALKF or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricGALKFMRK

Forward yield	1333.33% ✓	2.76%
Annual dividend / share	$2.00	$3.32 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	32.7% ✓
Portfolio after 10y	$241528700.61M ✓	$56.8K
Annual income after 10y	$210,475,860,072,406.56 ✓	$9,798.13
Total dividends collected	$239239876.27M ✓	$28.9K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: GALKF vs MRK ($10,000, DRIP)

Year	GALKF Portfolio	GALKF Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$144,033	$133,333.33	$11,206	$366.19	+$132.8K → GALKF
2	$1,948,924	$1,794,807.89	$12,650	$502.35	+$1.94M → GALKF
3	$24,782,219	$22,696,870.86	$14,407	$694.19	+$24.77M → GALKF
4	$296,245,945	$269,728,970.81	$16,585	$967.82	+$296.23M → GALKF
5	$3,330,378,004	$3,013,394,842.54	$19,342	$1,363.89	+$3330.36M → GALKF
6	$35,223,684,321	$31,660,179,856.69	$22,913	$1,947.19	+$35223.66M → GALKF
7	$350,636,384,108	$312,947,041,885.16	$27,662	$2,823.89	+$350636.36M → GALKF
8	$3,286,630,500,315	$2,911,449,569,318.85	$34,159	$4,173.35	+$3286630.47M → GALKF
9	$29,021,346,295,663	$25,504,651,660,325.88	$43,337	$6,308.80	+$29021346.25M → GALKF
10	$241,528,700,608,766	$210,475,860,072,406.56	$56,776	$9,798.13	+$241528700.55M → GALKF

GALKF vs MRK: Complete Analysis 2026

GALKF — Stock

Galantas Gold Corporation engages in the acquisition, exploration, and development of gold properties primarily in Omagh, Northern Ireland. The company owns and operates a producing open-pit gold mine near Omagh, which covers an area of 189 square kilometers. It also produces by-products of silver and lead. The company was formerly known as European Gold Resources Inc. and changed its name to Galantas Gold Corporation in May 2004. Galantas Gold Corporation was founded in 1996 and is based in Toronto, Canada.

Full GALKF Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →

📬

Get this GALKF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GALKF vs SCHD GALKF vs JEPI GALKF vs O GALKF vs KO GALKF vs MAIN GALKF vs JNJ GALKF vs ABBV GALKF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.